June 29 (Reuters) - EU Medicines Agency:
* EMA RECOMMENDS APPROVAL OF NOVARTIS GENE-BASED CELL THERAPY KYMRIAH
* EMA RECOMMENDS APPROVAL OF BAXALTA' INNOVATIONS' DRUG FOR VON WILLEBRAND DISEASE VONICOG ALFA
* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF ULTRAGENYX DRUG FOR TREATMENT OF SLY SYNDROME
* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF GILEAD SCIENCES' CAR-T TREATMENT FOR ADVANCED NON-HODGKIN LYMPHOMA YESCARTA Source text ID: (bit.ly/2Ky9Rwj) Further company coverage: